GLP 1 DRUG

After weight loss, Alzheimer's may be next frontier for drugs like Ozempic

Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several different aspects of the metabolic system implicated in Alzheimer's disease, including a protein called amyloid and inflammation, researchers say. The hope is that improving glucose utilisation and tamping down inflammation in the entire body, including the brain, could slow progression of debilitating diseases like Alzheimer's and Parkinson's.